Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €61.92 EUR
Change Today +1.39 / 2.29%
Volume 77.0K
MOR On Other Exchanges
As of 3:35 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by MORPHOSYS AG (MOR) in the last 6 months

Announced 05/7/15
20.00M for Lanthio Pharma B.V.

Morphosys AG (XTRA:MOR) acquired remaining 80.02% stake in Lanthio Pharma B.V. from BioGeneration Ventures B.V., INKEF Capital and Hanzepoort BV for €20 million on May 7, 2015. Thomas Schmid of Weil, Gotshal & Manges LLP and Jaap Stoop of NautaDutilh N.V. acted as legal advisors to Morphosys. Francois Koppenol of AKD lawyers & Civil-Law Notaries acted as a legal advisor to Lanthio Pharma B.V.

MOR's price was unchanged after the transaction was announced on 05/7/15.
Investor / Buyer
Morphosys AG
Creditor / Lender
BioGeneration Ventures B.V.
Hanzepoort BV
INKEF Capital
Legal Advisor
AKD lawyers & Civil-Law Notaries

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MOR:GR €61.92 EUR +1.39

MOR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ablynx NV €12.63 EUR +0.09
Genmab A/S kr603.00 DKK +26.00
ImmunoGen Inc $13.46 USD +0.48
Intrexon Corp $43.00 USD +1.23
XOMA Corp $0.84 USD +0.0598
View Industry Companies

Industry Analysis


Industry Average

Valuation MOR Industry Range
Price/Earnings 49.3x
Price/Sales 13.9x
Price/Book 4.2x
Price/Cash Flow 49.8x
TEV/Sales 11.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MORPHOSYS AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at